Jan/Feb 2022Jan/Feb 2022
PAYMENTform_banner200PAYMENTform_banner200
RATES_banner200RATES_banner200
SIGNUP_banner200SIGNUP_banner200
Magazine Flip
equineSUBSCRIBE_200animationequineSUBSCRIBE_200animation
EC_advertisng_RS200x345EC_advertisng_RS200x345
https://corroshop.com
paykwik al online sportwetten paykasa

AQHA- Medroxyprogesterone Acetate Violations to be Enforced Starting August 15th, 2021

Filed under: Breaking News,Health & Training |     

AQHA Publicity

The American Quarter Horse Association has received questions regarding the approval to add the drug, medroxyprogesterone acetate (MPA) (Depo-Provera) to the list of prohibited substances, per AQHA Rule VIO401. MPA is a synthetic progestin hormone administered to mares off-label in an attempt to suppress behavioral estrus.

MPA is not approved by the Food and Drug Administration (FDA) for use in horses and, effective August 15, 2021, AQHA will be enforcing violations as one of the Association’s prohibited substances to protect the welfare and integrity of the American Quarter Horse.

Read this MPA FAQ for more information.

paykwik online sportwetten paykasa